Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dorzolamide eye drops with intravitreal Avastin for diabetic macular edema
IRCT20131229015975N5Phase 3Completed
- Sponsor
- Isfahan University of Medical Sciences
- Start
- Sep 2017
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics, Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in diabetic macular edema (DME) comparing Avastin + dorzolamide with Avastin + artificial tears control (2 arms). Primary endpoints: Visual acuity, Central macular thickness and 1 more. Started Sep 2017; status: completed.
02
Drugs
dorzolamidebevacizumab
03
Conditions
diabetic macular edema (DME)
Beyond the preview
Go deeper on IRCT20131229015975N5.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20131229015975N5.